retatrutide phase 3 results october 2025 Today, we shared new data from two trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Retatrutide Availability & Timeline |

Link Kellner DA, Dente E, Tran V, et al

doi: 10.1016/j.neuropharm.2015.10.023 156 SaraivaC.Barata-AntunesS.SantosT.FerreiroE.CristovaoA

At Leva Medical , our specialists closely track these clinical developments to ensure patients in Queens, Elmhurst, and Forest Hills have access to the safest and most effective options available

When taken as recommended, weight loss injections boast a variety of benefits

Ryan JJ, Bateman HR, Stover A, Gomez G, Norton SK, Zhao W, et al: Fullerene nanomaterials inhibit the allergic response

Exenatide (Byetta, AstraZeneca) is a synthetic version of exendin-4, a GLP-1R agonist found in the saliva of the Gila monster ( Heloderma suspectum )